KLRK1 and glioblastoma: TMZ, which is the current standard of care for glioblastoma multiforme (GBM) together with radiotherapy after resection, might sensitize tumor cells to γδ T-cell recognition through upregulation of NKG2D ligands but it also causes lymphocytopenia that is avoided by MGMT expression (107).